Retail sale of pharmaceutical products
APOVEST AS
Revenue 2024
NOK 2.9m
Operating profit
NOK 123,000
Equity
NOK 5.0m
Incorporated
2009
Share capital
NOK 2.5m
Roles
Daglig lederHåvard Røkke
Regnskapsfører
Revisor
Styrets lederHåvard Røkke
StyremedlemSynne Standal Solheim
StyremedlemTerje Kvaal
VaramedlemHanna Haugen Strand
Auditor
Audit firm
SIGMA REVISJON AS
4 registrerte revisorer ved SIGMA REVISJON AS:
CATHRINE LOTHEStatsautorisert revisor
KENNETH GJØSTEIN VAULEStatsautorisert revisor
MARITA IREN DANIELSEN MENTZONIStatsautorisert revisor
YNGVE LEIKANGERStatsautorisert revisor
The Brønnøysund registers name the audit firm, not which individual auditor signs the accounts.
Auditor at related companies
3 of 3 companies in the same group use the same auditor.
| Company | Auditor | |
|---|---|---|
| DITT APOTEK AMFI OS AS | SIGMA REVISJON AS | same |
| SANDVIKEN APOTEK AS | SIGMA REVISJON AS | same |
| SUND APOTEK AS | SIGMA REVISJON AS | same |
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| NORSK MEDISINALDEPOT AS | 49.0% | 1228.000000 | 2025 |
| APOHOLD AS | 25.5% | 639.000000 | 2025 |
| RØKKE INVEST AS | 25.5% | 639.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| DITT APOTEK AMFI OS AS | Active | 100.0% | 100.000000 |
| SUND APOTEK AS | Active | 100.0% | 100.000000 |
| APOVEST DRIFT AS | Active | 100.0% | 100.000000 |
| SANDVIKEN APOTEK AS | Active | 100.0% | 900.000000 |
| FANA APOTEK AS | Active | 100.0% | 1000.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.